Emerging evidence demonstrates immune regulation of T cells may impact vitiligo progression, suggesting treatments could aid in repigmentation.
Emerging evidence demonstrates that self-reactive CD8 + T resident memory cells (T RM cells) may already populate the never-lesional (NL) skin of patients with chronic inflammatory conditions, including vitiligo. However, their functional activity and regulation remain unknown. By combining cellular and transcriptomic approaches, we show that common CD8 + T cell clusters with a similar transcriptional profile infiltrate NL and peri-lesional (PL) skin of patients with vitiligo. Pathways related to immune activation were more active in T cells from PL skin, while those related to immune regulation were enriched in NL skin T cells, also evidenced by the stronger infiltration of regulatory T cells and the higher expression of programmed cell death protein 1 (PD-1) by CD8 + T cells in NL skin. Treatment of patients with baricitinib led to an increase in regulatory T cells and CD8 + T cells expressing PD-1 in repigmented skin. These findings suggest that functional T cells populate pigmented skin in vitiligo and highlight the importance of regulatory mechanisms to restrain their activation and prevent depigmentation.
No takes yet. Share an insight, caveat, or question.
Migayron et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: